Anixa Biosciences, Inc.ANIXNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank14
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-12.27
↓ 41% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive declineCompressed
Average
-8.71
Historical baseline
PeriodValueYoY Change
2025-12.27-37.9%
2024-8.89+10.9%
2023-9.98+20.2%
2022-12.51-11.4%
2021-11.24-148.6%
2020-4.52+31.3%
2019-6.58-28.9%
2018-5.10-2.2%
2017-4.99+54.9%
2016-11.06-